IFNGR1 and rectal cancer: demonstrated that in rectal cancer, lysosomal sorting and degradation of IFNGR1(interferon gamma receptor 1) compromise the integrity of the IFNγ(interferon-gamma) and MHC-I signaling pathways, thereby promoting immune evasion and intrinsic resistance to immunotherapy in colorectal cancer (44).